-+ 0.00%
-+ 0.00%
-+ 0.00%

Q32 Bio files prospectus for USD 75 million at-the-market stock offering

PUBT·04/24/2026 20:11:08
Listen to the news
Q32 Bio files prospectus for USD 75 million at-the-market stock offering
  • Q32 Bio filed a new prospectus supplement to sell up to USD 75 million of common stock through its at-the-market program with Cantor Fitzgerald.
  • Company completed its prior ATM tranche, selling USD 14.2 million of common stock under the earlier prospectus supplement.
  • Sales will continue under the existing Controlled Equity Offering sales agreement signed March 27, 2026.
  • Additional shares will be issued off Q32 Bio’s effective Form S-3 shelf registration statement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-177178), on April 24, 2026, and is solely responsible for the information contained therein.